Contagion&reg Editorial Staff

Marin Kollef, MD, discusses what makes the 3-gram dose regimen of ceftolozane/tazobactam unique.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of July 21, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Glenn Tillotson, PhD, discusses possible avenues for future research on gram-negative skin infections and inappropriate empiric therapy.

Matthew Girgis, PharmD, PGY-2, discusses why it's advantageous to decrease patient exposure to vancomycin.

We asked providers in the field why they pursued a career in infectious disease.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of July 14, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Dr. Tedros has accepted the World Health Organization (WHO) International Health Regulations Emergency Committee's recommendation.

RECARBRIO (imipenem, cilastatin, and relebactam) has been approved for the treatment of complicated urinary tract infections and complicated intra-abdominal bacterial infections where there are limited or no alternative treatments available.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of July 7, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 30, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 23, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

As June draws to a close, the Contagion® editorial staff is recapping the trends and top infectious disease news of the month.

ACIP voted 10-to-4 to expand the recommended HPV vaccine “catch-up” age for men from 21 to 26, matching the existing guidelines for women.

According to a press release issued by the manufacturer, the products are the therapeutic equivalent to Genentech’s Tamiflu capsules.

Glenn Tillotson, PhD, explains how inappropriate empiric therapy can drive poor outcomes.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 16, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA has expanded the patient population and issued updated drug interactions, warnings, and precautions for Biktarvy.

The sNDA application is based on positive results from a Phase III, randomized, double-blind, study that compared the efficacy and safety of BAXDELA to moxifloxacin for the treatment of CABP.